Decrease of Very Late Activation Antigen-4 and CD36 on Reticulocytes in Sickle Cell Patients Treated With Hydroxyurea
Open Access
- 1 April 1997
- journal article
- Published by American Society of Hematology in Blood
- Vol. 89 (7), 2554-2559
- https://doi.org/10.1182/blood.v89.7.2554
Abstract
Sickle cell disease (SCD) is characterized by repeated vaso-occlusive events, which result in substantial morbidity. Abnormal adhesion of sickle red blood cells (RBC) to the vascular endothelium is postulated to play a role in the pathogenesis of vaso-occlusion. Two adhesion receptors, very late activation antigen-4 (VLA-4) and CD36, are found in unusually high numbers on sickle cell reticulocytes and do mediate adhesion of sickle RBC to endothelium. Hydroxyurea (HU) therapy results in fewer vaso-occlusive episodes, and we postulated that HU-related modulation of VLA-4 and CD36 receptors may contribute to its clinical benefit. Using flow cytometry, eight patients were followed from the onset of HU treatment through a mean treatment length of 200 ± 49 days. Mean corpuscular volume and percent fetal hemoglobin (Hb F ) increased from 87% ± 6% to 98% ± 9% and 6.6% ± 3.9% to 12.7% ± 5.6%, respectively. The percentage of reticulocytes expressing VLA-4 decreased from 29.0% ± 5.9% to 14.9% ± 2.3% (P = .0003). Two thirds of the total decrease in VLA-4 expression occurred after 10 weeks of HU and plateaued by 20 weeks. Changes in VLA-4 expression occurred before substantial increases in Hb F. The percentage of reticulocytes expressing CD36 decreased from 55.3% ± 6.4% to 42.6% (P = .0046). Changes in adhesion receptor expression were not caused by a decrease in reticulocytosis with HU therapy. This report is the first to associate a decrease in adhesion receptor expression with a therapy known to reduce the clinical severity of SCD.Keywords
This publication has 31 references indexed in Scilit:
- A critical role of VLA-4 in erythropoiesis in vivoBlood, 1996
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Roles for integrin very late activation antigen-4 in stroma-dependent erythropoiesisBlood, 1994
- Sickle cell vasoocclusion: Many issues and some answersCellular and Molecular Life Sciences, 1993
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Pain in Sickle Cell DiseaseNew England Journal of Medicine, 1991
- Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivoAmerican Journal of Hematology, 1989
- Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications.Proceedings of the National Academy of Sciences, 1989
- Erythrocyte Adherence to Endothelium in Sickle-Cell AnemiaNew England Journal of Medicine, 1980
- Abnormal Adherence of Sickle Erythrocytes to Cultured Vascular EndotheliumJCI Insight, 1980